(Q44483646)

3 December 2017

title

Effect of immunization on herpes simplex virus type 1 latent infection in the trigeminal ganglion (English)

1 reference

Herpes simplex virus type 1

3 December 2017

0 references

1 reference

Martha Kramer

1

1 reference

3 December 2017

Jennifer Riley

2

1 reference

3 December 2017

Amy Spoering

3

1 reference

3 December 2017

Donald Coen

4

1 reference

3 December 2017

David Knipe

5

1 reference

3 December 2017

language of work or name

1 reference

1 March 2003

1 reference

3 December 2017

1 reference

3 December 2017

volume

26

1 reference

3 December 2017

issue

3-4

1 reference

3 December 2017

page(s)

185-194

1 reference

Herpes simplex virus vaccines

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.26.3.185.14891

Prophylactic and therapeutic effects of human immunoglobulin on the pathobiology of HSV-1 infection, latency, and reactivation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.26.3.185.14891

Treatment of HSV-1 infection with immunoglobulin or acyclovir: comparison of their effects on viral spread, latency, and reactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.26.3.185.14891

The efficacy of a DNA vaccine encoding herpes simplex virus type 1 (HSV-1) glycoprotein D in decreasing ocular disease severity following corneal HSV-1 challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.26.3.185.14891

Efficacy of the herpes simplex virus types 1 and 2 mutant viruses to confer protection against zosteriform spread in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.26.3.185.14891

A growth and latency compromised herpes simplex virus type 2 mutant (ICP10DeltaPK) has prophylactic and therapeutic protective activity in guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.26.3.185.14891

Mechanisms of immunization with a replication-defective mutant of herpes simplex virus 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.26.3.185.14891

Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.26.3.185.14891

Protection from primary infection and establishment of latency by vaccination with a herpes simplex virus type 1 recombinant deficient in the virion host shutoff (vhs) function

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.26.3.185.14891

Protection against ocular and cutaneous infection with herpes simplex virus type 1 by intragastric immunization with live virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.26.3.185.14891

Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.26.3.185.14891

Immunofluorescence and electron microscopy of the cytoplasmic surface of the human erythrocyte membrane and its interaction with Sendai virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.26.3.185.14891

Restricted herpes simplex virus type 1 gene expression within sensory neurons in the absence of functional B and T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.26.3.185.14891

Establishment of latent herpes simplex virus type 1 infection in resistant, sensitive, and immunodeficient mouse strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.26.3.185.14891

Passive immunization protects the mouse eye from damage after herpes simplex virus infection by limiting spread of virus in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.26.3.185.14891

Immunological memory to herpes simplex virus type 1 glycoproteins B and D in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.26.3.185.14891

Restricted replication of herpes simplex virus in human monocyte cultures: Role of interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.26.3.185.14891

Endogenously produced interferon protects mice from herpes simplex virus type 1 corneal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.26.3.185.14891

Innate and acquired immunity to herpes simplex virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.26.3.185.14891

Recombinant interleukin-1 alpha, interleukin-2 and M-CSF-1 enhance the survival of newborn C57BL/6 mice inoculated intraperitoneally with a lethal dose of herpes simplex virus-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.26.3.185.14891

Vaccination with the immediate-early protein ICP47 of herpes simplex virus-type 1 (HSV-1) induces virus-specific lymphoproliferation, but fails to protect against lethal challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.26.3.185.14891

Cell-mediated immune responses in herpes simplex virus-infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.26.3.185.14891

Lymphocytes delay kinetics of HSV-1 reactivation from in vitro explants of latent infected trigeminal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.26.3.185.14891

A thymidine kinase-negative HSV-1 strain establishes a persistent infection in SCID mice that features uncontrolled peripheral replication but only marginal nervous system involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.26.3.185.14891

10.1076/CEYR.26.3.185.14891

21 January 2018

Identifiers

DOI

1 reference

3 December 2017

1 reference